Canadian billionaire Prem Watsa's Fairfax Group and Bain Capital are in competition for a buyout of Farmson Basic Drugs, a leading API make...

After massive annual increases of 12% and 10% in prices on record last year and in 2022, this will be a meagre increase for the pharma indu...

Drug maker Granules India reported a marginal rise in third-quarter profit on Tuesday, helped by easing raw material costs.

The Ludhiana-based company generates about 30% of its ₹2,216 crore revenues from the commodity API ibuprofen, where it is vertically integr...

Dolo-650 being unethically prescribed to patients during the pandemic is just the latest example of drug companies’ malpractices, senior ad...

Themis had launched inosine pranobex under brand name Viralex in June this year. Despite the drug not figuring in the government's Covid tr...

The third wave has been fuelled by the Omicron variant, which is highly infectious yet milder, causing flu-like symptoms such as fever, bod...

The prices of active pharmaceutical ingredients (APIs), excipients, glass vials and packaging material, among other inputs, have escalated ...

“We endorse the Indian government’s stand asking for a waiver of the TRIPS provisions to deal with the Covid-19 crisis. This is the time fo...

Resumption of normal supplies has also calmed worries, at least for now, about the Sino-Indian border standoff affecting imports from China...

India, the world’s third-largest drug producer by volumes, imports 70% of its APIs from China. For some APIs, especially antibiotics, depen...

The company is one of the active ingredients and drug formulations makers.

In a letter to the chief secretaries, the National Pharmaceutical Pricing Authority (NPPA) has asked them to ensure that there is no violat...

Increased cost of production and other European economy related constraints had led to several local drug makers shutting down their unviab...

Several drug makers and trade body representatives want the government to focus on attaining self-sufficiency in producing key raw material...

Drug maker Granules India is looking for acquisitions or partnerships in China, Greece, Malta and South Africa to expand capacity and boost...

Prices of commonly used medicines such as paracetamol, nimesulide, cetrizine and omeprazole are set to come down sharply.